Inventor · disambiguated record
Donglei Liu
Also filed as: LIU DONGLEI
12 granted patents·5 pending applications·96 citations·filing 2002–2024
88Inventor score
Files withARTMAN III GERALD DAVID6BAYER PHARMACEUTICALS CORP4NOVARTIS AG4ADAMS CHRISTOPHER M1BAUSCH & LOMB IRELAND LTD1
Top patents by PatentIndex Score
17 records- 0196US8501756B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Aug 6, 2013·65 cites·3 claims
- 0293US11845730B21,3-substituted cyclobutyl derivatives and uses thereofNOVARTIS AG·Filed 2022·Granted Dec 19, 2023·2 cites·30 claims
- 0385US6900205B21,8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 31, 2005·19 cites·36 claims
- 0480US8242125B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2009·Granted Aug 14, 2012·3 cites·19 claims
- 0577US12435040B21,3-substituted cyclobutyl derivatives and uses thereofBAUSCH & LOMB IRELAND LTD·Filed 2023·Granted Oct 7, 2025·0 cites·19 claims
- 0676US7109196B21,8 Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 19, 2006·7 cites·20 claims
- 0771US2025214989A1Naphthyridinone derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0870US12084442B2Naphthyridinone derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2022·Granted Sep 10, 2024·0 cites·21 claims
- 0969US2024391941A1Naphthyridinone derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1062US8541432B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Sep 24, 2013·0 cites·3 claims
- 1162US8492393B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Jul 23, 2013·0 cites·6 claims
- 1262US8486954B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Jul 16, 2013·0 cites·3 claims
- 1362US8431584B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Apr 30, 2013·0 cites·6 claims
- 1459US2006189609A11, 8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 1543US2007213339A1Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative ConditionsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 1641US2016145247A1Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereofBELANGER DAVID B·Filed 2014·Application pending·0 cites
- 1732US9765067B2Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activatorsADAMS CHRISTOPHER M·Filed 2015·Granted Sep 19, 2017·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Donglei Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →